CBT-i
No, most CBT-I (Cognitive Behavioral Therapy for Insomnia) and CBT-I-based apps do not require insurance or a prescription.
There are two main routes. Prescription digital treatments, such as SleepioRx and Somryst, must be ordered by a licensed healthcare provider. Whether they are covered, and how much you pay, depends on your insurance plan.
Many consumer CBT-I apps take a more direct approach. You can download the app, create an account, and begin without a prescription, referral, or insurance claim. Prescription options may be a better fit for people who want clinician oversight or can access the treatment through their health plan.
Rest follows the direct-access model. You can download it and start logging your sleep immediately, without a prescription, referral, or waitlist. Rest includes a free tier, while its paid subscription is purchased directly rather than billed through insurance.
So, if concerns about insurance have been stopping you from trying CBT-I, they do not need to. A direct-access app allows you to begin working on your sleep without waiting for an appointment with a CBT-I specialist.
Learn more in our full guide: The Best CBT-I Apps (2026).
Disclaimer: Rest is a self-management and well-being tool for sleep improvement and is not intended to diagnose, treat, cure, or prevent any disease. It does not replace care by your healthcare provider or any treatments you may be using. Always continue to take your medications as directed by your healthcare provider. The information provided in the Rest app and related materials is intended for your general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Use Rest only as directed. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. If you have or suspect you have a specific medical condition or disease, please consult your healthcare provider before using the Rest program.
Company: Evolve Global, Inc.